Chinese Journal of Pharmacovigilance ›› 2016, Vol. 13 ›› Issue (12): 733-736.

• Orginal Article • Previous Articles     Next Articles

Risk Analysis and Control of Compound Resorcinol Lotion in China Hospital Preparations Specifications

WANG Li1, MA Cong2, LEI Jia-hao2, ZHANG Yan3, MA Jun-qiang4, MA Pei-jie1, *, ZHAO Ting1   

  1. 1 Department of Pharmacy, Baoji Municipal Center Hospital, Shanxi Baoji 721008, China;
    2 First Clinical Medical College of Nanchang University, Jiangxi Nanchang 330031, China;
    3 Department of Primary Health Care, Baoji Maternal and Child Health, Shanxi Baoji 721000, China;
    4 Department of Electronic and Information Engineering, Baoji Vocational and Technical College, Shanxi Baoji 721013, China
  • Received:2017-01-13 Revised:2017-01-13 Online:2016-12-20 Published:2017-01-13

Abstract: Objective To provide the reference for amending the risk control and quality standards of lotion by analyzing the risk of compound resorcinol lotion, including prescription, preparation, test and use. Methods Based on searching literatures from CNKI, the analysis showed that compound resorcinol lotion in China Hospital Preparations Specifications carried risk. Results The compound resorcinol lotion formula has excessive amounts of toxic substance. During its preparation, toxic substance can be absorbed by skin and respiratory tract. Toxic substance concentration can not be strictly controlled when testing compound resorcinol lotion. The risk can be added up when using this lotion for a long time. Conclusion It is necessary to evaluate the risk of compound resorcinol lotion and improve its quality standards.

Key words: phenol, m-dihydroxybenzene, risk, revaluation, compound resorcinol lotion

CLC Number: